DELMAR PHARMACEUTICALS INC's ticker is DMPI and the CUSIP is 247078207. A total of 6 filers reported holding DELMAR PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | +100.0% | 4,262 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 4,262 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 4,262 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -25.0% | 4,262 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | -20.0% | 4,262 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 4,262 | -50.0% | 0.00% | – |
| Q3 2017 | $7,000 | -65.0% | 8,524 | 0.0% | 0.00% | – |
| Q2 2017 | $20,000 | -44.4% | 8,524 | 0.0% | 0.00% | – |
| Q1 2017 | $36,000 | +5.9% | 8,524 | 0.0% | 0.00% | – |
| Q4 2016 | $34,000 | -34.6% | 8,524 | 0.0% | 0.00% | – |
| Q3 2016 | $52,000 | – | 8,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 129,580 | $413,000 | 0.00% |
| Hartford Financial Management Inc. | 180 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 14,962 | $48,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 8,524 | $34,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 400 | $1,000 | 0.00% |
| UBS Group AG | 378 | $1,000 | 0.00% |